Skip to main content

ALFACALCIDOL

 ALFACALCIDOL


BRAND NAME:- ONE ALPHA, ALPHA D3, ALHPADOL 0.25 and 1ug caps ALFACAL 0.25,0.5 ug caps.



ALFACALCIDOL is an analogue of vitamin D Used for supplementation in human and as a poultry feed additive .It is 1 alpha-OHD3— a prodrug that is rapidly hydroxylated in the liver to 1,25 (OH)2 D3 or calcitriol. 

Therefore,it does not require hydroxylation at position 1 which is the limiting step in the generation of active from of vit.D, and which takes place in the kidney. 

ALFACALCIDOL has a weaker impact on calcium metabolism and parathyroid hormone levels than calcitriol .



BIOAVAILABILITY ACTION:-

ALFACALCIDOL is orally active and clinically equally effective on long term basis to calcitriol. It's metabolic activation in liver does not pose a problem even in severe liver disease.

Repeated serum calcium measurements are essential for regulation of maintenance dose. Hypercalcaemia should be watched for and therapy promptly interrupted for few days when it develops.


USED:- it is effective in renal bone disease,vit D dependent rickets ,vit D resistant rickets ,hypoparathyroidism ,it is also being Used in osteoporosis


DOSE:- 1-2ug/day, children<20kg 0.5ug/ day.


SIDE EFFECTS:-Weakness,Fatigue,Sleepiness,Headache,Loss of appetite,Dry mouth,Metallic taste,Nausea,Vomiting etc.





Labels:

Comments

Post a Comment

Popular posts from this blog

Cefpodoxime proxetil Uses, Side Effects, and More

 Cefpodoxime proxetil Brand name:- cefoprox ,cepodem,DOXCEF 100,200mg cap.  Cefpodoxime Proxetil is an antibiotic. It kills the bacteria by preventing them from forming the bacterial protective covering (cell wall) which is needed for them to survive. Pharmacodynamic:-  Cefpodoxime is shown to be effective against most Gram positive and Gram negative bacteria, except Pseudomonas aeruginosa, Enterococcus, and Bacteroides fragilis. Mechanism of action:-  Cefpodoxime is active against a wide spectrum of Gram-positive and Gram-negative bacteria. Cefpodoxime is stable in the presence of beta-lactamase enzymes. As a result, many organisms resistant to penicillins and cephalosporins, due to their production of beta-lactamase, may be susceptible to cefpodoxime. Cefpodoxime is inactivated by certain extended spectrum beta-lactamases. The bactericidal activity of cefpodoxime results from its inhibition of cell wall synthesis. The active metabolite of cefpodoxime binds preferentially to penicilli
Post a Comment
Read more

Cephalexin ( ZYD ) ( Cefalexin ) Uses, Side Effects, and More

 Cephalexin (ZYD) (Cefalexin) Brand name:-  Cephacillin 250,500mg cap; Sporidex, Alcephin,Cephaxin cap. Cephalexin (also called Cefalexin)  is the most common used orally effective first generation cephalosporin , similar in spectrum to cefazolin , but less active against penicillinase producing staphylococci and H. Influenza. Plasma protein binding is low; it attains High concentration in bile and is excreted unchanged in urine; t½ - 60min. Pharmacodynamic:-  Cephalexin (also called Cefalexin) is a first generation cephalosporin antibiotic. It is one of the most widely prescribed antibiotics, often used for the treatment of superficial infections that result as complications of minor wounds or lacerations.Label It is effective against most gram-positive bacteria through its inihibition of the cross linking reaction between N-acetyl muramicacid and N-acetylglucosamine in the cell wall, leading to cell lysis. Pharmacokinetics:- Cephalexin is rapidly and almost completely absorbed from t
Post a Comment
Read more

BASILIXIMAB Uses, Side Effects, and More

 BASILIXIMAB BRAND NAME:- Simulect   BASILIXIMAB is another anti CD - 25 antibody with higher affinity for the IL-2 receptor, but shorter plasma t½ (1 week) . is a monoclonal antibody used to prevent rejection in kidney transplants. It is a chimeric mouse-human monoclonal antibody to the α chain (CD25) of the IL-2 receptor of T cells. It is used in combination with other medicines used to prevent organ rejection. PHARMACODYNAMIC:- Basiliximab functions as an IL-2 receptor antagonist. Specifically it inhibits IL-2-mediated activation of lymphocytes, a critical pathway in the cellular immune response involved in allograft rejection.  MECHANISM OF ACTION:-  Basiliximab competes with IL-2 to bind to the alpha chain subunit of the IL2 receptor on the surface of the activated T lymphocytes and thus prevents the receptor from signaling. This prevents T cells from replicating and also from activating B cells, which are responsible for the production of antibodies, which would bind to the trans
1 comment
Read more